Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkac045
Abstract: Abstract Introduction The use of oral fosfomycin for urinary tract infections (UTIs) caused by non-Escherichia coli uropathogens is uncertain, including Klebsiella pneumoniae, the second most common uropathogen. Methods A multicompartment bladder infection in vitro model… read more here.
Keywords: fosfomycin; klebsiella pneumoniae; oral fosfomycin; bladder infection ... See more keywords
Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection model
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkac402
Abstract: Abstract Objectives Pharmacodynamic profiling of oral ciprofloxacin dosing for urinary tract infections caused by ceftriaxone-resistant Escherichia coli isolates with ciprofloxacin MIC ≥ 0.25 mg/L. Background Urine-specific breakpoints for ciprofloxacin do not exist. However, high urinary concentrations may… read more here.
Keywords: bladder infection; ciprofloxacin; ceftriaxone resistant; model ... See more keywords
The immune responses to different Uropathogens call individual interventions for bladder infection
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.953354
Abstract: Urinary tract infection (UTI) caused by uropathogens is the most common infectious disease and significantly affects all aspects of the quality of life of the patients. However, uropathogens are increasingly becoming antibiotic-resistant, which threatens the… read more here.
Keywords: immune responses; infection; bladder infection; responses different ... See more keywords